Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 58 (2024): Issue 2 (June 2024)
Open Access
Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors
Maria Ingenerf
Maria Ingenerf
,
Christoph Auernhammer
Christoph Auernhammer
,
Roberto Lorbeer
Roberto Lorbeer
,
Michael Winkelmann
Michael Winkelmann
,
Shiwa Mansournia
Shiwa Mansournia
,
Nabeel Mansour
Nabeel Mansour
,
Nina Hesse
Nina Hesse
,
Kathrin Heinrich
Kathrin Heinrich
,
Jens Ricke
Jens Ricke
,
Frank Berger
Frank Berger
and
Christine Schmid-Tannwald
Christine Schmid-Tannwald
| Apr 14, 2024
Radiology and Oncology
Volume 58 (2024): Issue 2 (June 2024)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Apr 14, 2024
Page range:
196 - 205
Received:
Dec 08, 2023
Accepted:
Feb 20, 2024
DOI:
https://doi.org/10.2478/raon-2024-0024
Keywords
neuroendocrine tumors
,
liver metastases
,
CAPTEM therapy
,
clinical parameters
,
MR imaging
,
treatment response
© 2024 Maria Ingenerf et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.